. What is the status of efforts to characterize the human cancer genome?The National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) recognize the potential benefit that a comprehensive collection of genetic and epigenetic alterations for major cancers could provide to the cancer community.

A new study finds that a cancer vaccine combined with hormone-deprivation therapy can help patients with recurrence of prostate cancer. The results of this clinical trial, led by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health, appear in the August 2005 issue of the Journal of Urology.*

A new report released today by the National Cancer Institute, part of the National Institutes of Health, finds that high rates of cervical cancer are indicators of larger problems in access to health care. The report also finds that cervical cancer mortality, which is higher in certain geographic areas and populations, is a marker for […]

Researchers at the University of Minnesota Cancer Center and the National Cancer Institute (NCI), part of the National Institutes of Health, have discovered a new method that could accelerate the way cancer-causing genes are found and could lead to a more accurate identification of the genes, according to two studies in the July 14, 2005, […]